BRPI0514907A - derivados do pirrol [3,2 -c] piridina e processos para a sua preparação - Google Patents

derivados do pirrol [3,2 -c] piridina e processos para a sua preparação

Info

Publication number
BRPI0514907A
BRPI0514907A BRPI0514907-0A BRPI0514907A BRPI0514907A BR PI0514907 A BRPI0514907 A BR PI0514907A BR PI0514907 A BRPI0514907 A BR PI0514907A BR PI0514907 A BRPI0514907 A BR PI0514907A
Authority
BR
Brazil
Prior art keywords
pyridine derivatives
processes
preparation
pyrrol
pharmaceutically acceptable
Prior art date
Application number
BRPI0514907-0A
Other languages
English (en)
Inventor
Jae-Gyu Kim
Byung-Nak Ahn
Hyouk-Woo Lee
Suk-Won Yoon
Young-Ae Yoon
Hyun-Ho Choi
Heui-Il Kang
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of BRPI0514907A publication Critical patent/BRPI0514907A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

DERIVADOS DO PIRROL ¢3,2 -C! PIRIDINA E PROCESSOS PARA A SUA PREPARAçãO A presente invenção fornece novos derivados do pirrol ¢3,2 - c! piridina ou seus sais farmaceuticamente aceitáveis, processos para sua preparação e composições contendo os mesmos. Os derivados do pirrol ¢3,2 - c! piridina ou seus sais farmaceuticamente aceitáveis da presente invenção apresentam efeito excelente na inibição da bomba de prótons e são capazes de obter um efeito inibidor da bomba de prótons reversível.
BRPI0514907-0A 2004-09-03 2005-09-03 derivados do pirrol [3,2 -c] piridina e processos para a sua preparação BRPI0514907A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040070534 2004-09-03
PCT/KR2005/002925 WO2006025715A1 (en) 2004-09-03 2005-09-03 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
BRPI0514907A true BRPI0514907A (pt) 2008-06-24

Family

ID=36000317

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514907-0A BRPI0514907A (pt) 2004-09-03 2005-09-03 derivados do pirrol [3,2 -c] piridina e processos para a sua preparação

Country Status (15)

Country Link
US (1) US7541366B2 (pt)
EP (1) EP1805177B9 (pt)
JP (1) JP4989477B2 (pt)
KR (1) KR100946220B1 (pt)
CN (1) CN100564379C (pt)
AT (1) ATE466013T1 (pt)
AU (1) AU2005280739B2 (pt)
BR (1) BRPI0514907A (pt)
CA (1) CA2579083C (pt)
DE (1) DE602005020957D1 (pt)
DK (1) DK1805177T3 (pt)
ES (1) ES2342478T3 (pt)
MX (1) MX2007002076A (pt)
RU (1) RU2375359C2 (pt)
WO (1) WO2006025715A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012000275A (es) 2009-07-09 2012-02-08 Raqualia Pharma Inc Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
SG10201912699RA (en) 2015-07-20 2020-02-27 Genzyme Corp Colony stimulating factor-1 receptor (csf-1r) inhibitors
CA3162253A1 (en) * 2019-12-17 2021-06-24 C. David Allis Inhibitors of enl/af9 yeats
EP4267573A1 (en) 2020-12-23 2023-11-01 Genzyme Corporation Deuterated colony stimulating factor-1 receptor (csf-1r) inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
JP3465827B2 (ja) * 1993-02-24 2003-11-10 株式会社日清製粉グループ本社 アザインドール誘導体およびこれを有効成分とする抗潰瘍薬
US5451566A (en) * 1993-11-17 1995-09-19 Zeneca Limited Herbicidal pyrrolopyridine compounds
CZ283216B6 (cs) * 1994-01-19 1998-02-18 Sankyo, Company Limited Pyrrolopyridazinové deriváty
SE9704404D0 (sv) * 1997-11-28 1997-11-28 Astra Ab New compounds
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
FR2822463B1 (fr) * 2001-03-21 2004-07-30 Lipha Derives bicycliques de guanidines et leurs applications en therapeutique
US7361671B2 (en) 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
TW200301251A (en) * 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

Also Published As

Publication number Publication date
MX2007002076A (es) 2007-03-29
CN100564379C (zh) 2009-12-02
ES2342478T3 (es) 2010-07-07
ATE466013T1 (de) 2010-05-15
DK1805177T3 (da) 2010-08-02
CA2579083C (en) 2011-06-14
JP2008511619A (ja) 2008-04-17
AU2005280739A1 (en) 2006-03-09
EP1805177A4 (en) 2009-07-29
AU2005280739B2 (en) 2010-11-11
WO2006025715A1 (en) 2006-03-09
RU2375359C2 (ru) 2009-12-10
CN101010322A (zh) 2007-08-01
EP1805177B1 (en) 2010-04-28
US20070249658A1 (en) 2007-10-25
DE602005020957D1 (de) 2010-06-10
KR20060051003A (ko) 2006-05-19
EP1805177A1 (en) 2007-07-11
CA2579083A1 (en) 2006-03-09
EP1805177B9 (en) 2010-09-15
RU2007112111A (ru) 2008-10-10
KR100946220B1 (ko) 2010-03-08
US7541366B2 (en) 2009-06-02
HK1105978A1 (en) 2008-02-29
JP4989477B2 (ja) 2012-08-01

Similar Documents

Publication Publication Date Title
BRPI0514925A (pt) derivados de pirrol[2,3-c]piridina e processos para a preparação destes
WO2006023515A3 (en) Novel thiazole inhibitors of fructose 1,6-bisphosphatase
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
WO2007048066A3 (en) Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
NO20075152L (no) Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
NO20071095L (no) Hittil ukjente tiofenderivater
WO2004087699A3 (en) Thiazoles useful as inhibitors of protein kinases
WO2004087698A3 (en) Thiazoles useful as inhibitors of protein kinases
WO2004063151A3 (en) Novel tyrosine kinase inhibitors
ATE365742T1 (de) 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
WO2003091259A8 (en) Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
WO2007058832A3 (en) Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2009013348A3 (en) Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
AU2003250471A1 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
BRPI0514843A (pt) derivados de pirrolo[3,2-c] piridina e processos para a preparação dos mesmos
WO2004110990A3 (en) Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
WO2006110173A3 (en) Novel compounds
BRPI0514907A (pt) derivados do pirrol [3,2 -c] piridina e processos para a sua preparação
WO2006072000A3 (en) Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]